Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00449085

Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense Webster SOUNDSTAR 3D Diagnostic Ultrasound. A Feasibility Study

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Biosense Webster, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Feasibility study to evaluate CARTO™ XP EP Navigation System V9 and SOUNDSTAR 3D Diagnostic Ultrasound Catheter.

Detailed description

To construct geometric representation of the heart chambers using intracardiac ultrasound.The Carto™ XP Electrophysiology (EP) Navigation System v9 is intended to acquire real-time catheter based cardiac electrophysiogical maps.

Conditions

Interventions

TypeNameDescription
PROCEDUREElectrophysiology
DEVICECARTO™ XP EP Navigation System V9

Timeline

Start date
2007-04-01
Primary completion
2012-07-01
First posted
2007-03-19
Last updated
2025-02-03

Source: ClinicalTrials.gov record NCT00449085. Inclusion in this directory is not an endorsement.